• Caris Life Sciences to Present at 31st Annual Piper Jaffray Healthcare Conference

    IRVING, Texas, November 20, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Brian J. Brille, Vice Chairman of the Company, will present at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019, at 12:50 p.m. Eastern Time at … Read More

  • Caris Life Sciences to Present at Two Investor Healthcare Conferences

    IRVING, Texas, November 7, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Brian J. Brille, Vice Chairman of the Company, will present at two upcoming investor healthcare conferences in New York City. Presentation details are as follows:   Stifel 2019 Healthcare … Read More

  • St. Joseph Hospital Joins Caris Life Sciences’ Precision Oncology Alliance

    St. Joseph Hospital’s Center for Cancer Prevention and Treatment becomes member of Caris’ collaborative network dedicated to making cancer treatment more precise and effective   IRVING, Texas & ORANGE, Calif., October 30, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that St. … Read More

  • Caris Life Sciences Further Bolsters Scientific Advisory Board With Four New Members

    Industry thought leaders join a distinguished group of experts to advance Caris’ mission to expand the role of precision medicine in cancer care   IRVING, Texas, October 15, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today the addition of four members to its Scientific … Read More

  • Caris Life Sciences to Present New Research Across Tumor Types at ESMO Congress 2019

    Presentations include findings on biomarkers in rare, untreatable form of testicular cancer, and analysis of differential responses to BRAF inhibitors in melanoma and colorectal cancers   IRVING, Texas, September 19, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that it will present … Read More